Related Experiment Videos
Surgery of biliary atresia
1Section of Pediatric Surgery, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. mikko.pakarinen@hus.fi
Summary
Biliary atresia (BA) is a neonatal liver disease causing bile duct obstruction. Early Kasai portoenterostomy offers palliative treatment, with some infants surviving into adulthood with their native liver.
Area of Science:
- Pediatric Surgery
- Hepatology
- Neonatal Medicine
Background:
- Biliary atresia (BA) is a progressive, fibro-obliterative cholangiopathy impacting the neonatal biliary tree.
- It leads to obstructive bile flow and cholestasis, necessitating prompt diagnosis and intervention.
- The precise etiology of BA remains unclear.
Purpose of the Study:
- To outline the diagnostic and therapeutic approach for biliary atresia.
- To emphasize the critical timing of surgical intervention for improved outcomes.
- To present survival data following Kasai portoenterostomy.
Main Methods:
- Diagnostic work-up to rule out or confirm BA without delay.
- Kasai portoenterostomy as the primary palliative surgical procedure.
- Liver transplantation as a salvage option for treatment failure.
Main Results:
- Early Kasai portoenterostomy improves the chances of success in establishing bile drainage.
- Actuarial 5-year native liver survival rates after portoenterostomy range from 30% to 60%.
- Approximately 20% of patients treated with Kasai portoenterostomy in infancy survive to adulthood with their native liver.
Conclusions:
- Kasai portoenterostomy is the first-line surgical treatment for biliary atresia.
- Liver transplantation is reserved for cases where portoenterostomy is unsuccessful or liver function declines.
- Timely intervention is crucial for optimizing long-term outcomes in BA patients.